Global Small Molecule API Market Research Report- Forecast to 2027

Global Small Molecule API Market Research Report- Forecast to 2027

ID: MRFR/HC/0279-CRR | August, 2016 | Region: Global | 85 pages | Cooked Research Reports

Global Small Molecule API Market Information, by Types (Synthetic/Chemical API, Biological API), by Application (Cardiovascular, Oncology, Diabetes, Immunological Disorders and Others), by Manufacturing Method (In-House, Contract) - Forecast To 2027

Market Synopsis of Small Molecule API Market:


Market Scenario:


Globally the market for small molecule API is increasing rapidly. The major factors that drive the growth of small molecule API are rise in demand for the small molecule drugs, entry of big CMO’s into the business, Development in the infrastructure in the pharmaceutical industry, rising access to the medication in the people from developing and underdeveloped countries and others. Globally the market for small molecule API is expected to grow at the rate of about 7.0% from 2016 to 2027.


Key Finding:



  • The global small molecule API market and is expected to reach $279.7 billion by 2027.

  • Synthetic/Chemical API holds the largest share of 81.4% of the global small molecule API market.

  • North America holds the largest market share of 38% of global small molecule API market and is anticipated to reach $106.3 billion by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 7.3% during the forecast period.

  • Cardiovascular disorder segment holds the largest market share in 2015, and expected to continue the similar growth throughout the forecast period.


Global Small Molecule API Market, by Application


Global Small Molecule API Market, by Application
Study objectives of Small Molecule API Market:



  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the small molecule API market

  • To provide insights about factors affecting the market growth

  • To analyze the small molecule API market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by applications, manufacturing methods, and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global small molecule API market.


Intended Audience



  • Small Molecule Drug manufacturers & Suppliers

  • API manufacturers & Suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities


Segments:                                                                                                                                        

Global small molecule API market has been segmented on the basis of types which comprises of synthetic/chemical API, biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes, immunological disorders and others. On the basis of manufacturing method, market is segmented into In-house, Contract manufacturing.


Key Players for Small Molecule API Market:                                                


Some of the key players in this market are: Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd, Glaxosmithkline Plc, Lonza, Merck Sharp & Dohme Corp., Mylan N.V., Novartis AG, Pfizer Inc., Siegfried AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd and others.

Regional Analysis of Small Molecule API Market:  
                                               


Globally North America is the largest market for small molecule API. Europe is the second-largest market for small molecule API. Furthermore Asia pacific market is expected to be the fastest growing market for small molecule API.


The report for Global Small Molecule API Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3.1 DRIVERS

3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS

3.1.2 GROWING TREND OF OUTSOURCING

3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS

3.2 RESTRAINTS

3.2.1 AUSTERITY MEASURES IN EUROPE

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5.1 SYNTHETIC/CHEMICAL API

5.2 BIOLOGICAL API

6.1 CARDIOVASCULAR

6.2 ONCOLOGY

6.3 DIABETES

6.4 IMMUNOLOGICAL DISORDERS

7.1 IN-HOUSE MANUFACTURING

7.2 CONTRACT MANUFACTURING

7.2.1 INTRODUCTION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA-PACIFIC

8.3.1 INTRODUCTION

8.4 MIDDLE EAST & AFRICA

8.4.1 INTRODUCTION

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10.1 ALBEMARLE CORPORATION

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 ALLERGAN PLC

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 AUROBINDO PHARMA

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALs

10.3.4 STRATEGY

10.3.5 KEY DEVELOPMENT

10.4 CAMBREX CORPORATION

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 DR. REDDY’S LABORATORIES LTD.

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 GLAXOSMITHKLINE PLC

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 STRATEGY

10.6.5 KEY DEVELOPMENTS

10.7 LONZA

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 STRATEGY

10.7.5 KEY DEVELOPMENTS

10.8 MERCK SHARP & DOHME CORP.

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIAL

10.8.4 KEY DEVELOPMENTS

10.9 MYLAN N.V.

10.9.1 OVERVIEW

10.9.2 PRODUCT OVERVIEW

10.9.3 FINANCIALS

10.9.4 KEY DEVELOPMENTS

10.10 NOVARTIS AG

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 STRATEGY

10.10.5 DEVELOPMENTS

10.11 PFIZER INC.

10.11.1 OVERVIEW

10.11.2 PRODUCT OVERVIEW

10.11.3 FINANCIALS

10.11.4 KEY DEVELOPMENTS

10.12 SIEGFRIED AG

10.12.1 OVERVIEW

10.12.2 PRODUCT OVERVIEW

10.12.3 FINANCIALS

10.12.4 KEY DEVELOPMENTS

10.13 SUN PHARMACEUTICAL INDUSTRIES LTD.

10.13.1 OVERVIEW

10.13.2 PRODUCT OVERVIEW

10.13.3 FINANCIALS

10.13.4 KEY DEVELOPMENTS

10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD

10.14.1 OVERVIEW

10.14.2 PRODUCT OVERVIEW

10.14.3 FINANCIALs

10.14.4 STRATEGY

10.14.5 KEY DEVELOPMENTS

TABLE 1 GLOBAL SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 21
TABLE 2 GLOBAL SYNTHETIC/CHEMICAL API MARKET, BY REGION, 2014-2027 (USD MILLION) 22
TABLE 3 GLOBAL BIOLOGICAL API MARKET, BY REGION, 2014-2027 (USD MILLION) 23
TABLE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 25
TABLE 5 GLOBAL SMALL MOLECULE API MARKET: CARDIOVASCULAR, BY REGION, 2014-2027 (USD MILLION) 26
TABLE 6 GLOBAL SMALL MOLECULE API MARKET: ONCOLOGY, BY REGION, 2014-2027 (USD MILLION) 27
TABLE 7 GLOBAL SMALL MOLECULE API MARKET: DIABETES, BY REGION, 2014-2027 (USD MILLION) 28
TABLE 8 GLOBAL SMALL MOLECULE API MARKET: IMMUNOLOGICAL DISORDERS, BY REGION, 2014-2027 (USD MILLION) 29
TABLE 9 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 31
TABLE 10 GLOBAL SMALL MOLECULE API MARKET, BY IN-HOUSE MANUFACTURING, 2014-2027 (USD MILLION) 32
TABLE 11 GLOBAL SMALL MOLECULE API MARKET, BY CONTRACT MANUFACTURING, 2014-2027 (USD MILLION) 33
TABLE 12 GLOBAL SMALL MOLECULE API MARKET, BY REGION, 2014-2027 (USD MILLION) 37
TABLE 13 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY, 2014-2027 (USD MILLION) 38
TABLE 14 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 39
TABLE 15 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 40
TABLE 16 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 41
TABLE 17 U.S. SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 42
TABLE 18 U.S. SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 43
TABLE 19 U.S. SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 43
TABLE 20 CANADA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 44
TABLE 21 CANADA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 44
TABLE 22 CANADA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 45
TABLE 23 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY, 2014-2027 (USD MILLION) 46
TABLE 24 EUROPE SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 47
TABLE 25 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 48
TABLE 26 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 49
TABLE 27 GERMANY SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 50
TABLE 28 GERMANY SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 50
TABLE 29 GERMANY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 51
TABLE 30 FRANCE SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 51
TABLE 31 FRANCE SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 52
TABLE 32 FRANCE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 52
TABLE 33 U.K. SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 53
TABLE 34 U.K. SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 53
TABLE 35 U.K. SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 54
TABLE 36 ITALY SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 54
TABLE 37 ITALY SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 55
TABLE 38 ITALY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 55
TABLE 39 SPAIN SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 56
TABLE 40 SPAIN SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 56
TABLE 41 SPAIN SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 57
TABLE 42 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY, 2014-2027 (USD MILLION) 58
TABLE 43 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 59
TABLE 44 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 60
TABLE 45 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 61
TABLE 46 JAPAN SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 62
TABLE 47 JAPAN SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 62
TABLE 48 JAPAN SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 63
TABLE 49 CHINA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 63
TABLE 50 CHINA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 64
TABLE 51 CHINA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 64
TABLE 52 INDIA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 65
TABLE 53 INDIA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 65
TABLE 54 INDIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 66
TABLE 55 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 67
TABLE 56 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 67
TABLE 57 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 68
TABLE 58 AUSTRALIA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 69
TABLE 59 AUSTRALIA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 69
TABLE 60 AUSTRALIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 70
TABLE 61 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY REGION, 2014-2027 (USD MILLION) 71
TABLE 62 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 73
TABLE 63 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 74
TABLE 64 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 75

FIGURE 1 RESEARCH PROCESS 13
FIGURE 2 PORTERS FIVE FORCES MODEL 18
FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 21
FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 31
FIGURE 5 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 34
FIGURE 6 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 38
FIGURE 7 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 39
FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 40
FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 41
FIGURE 10 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46
FIGURE 11 EUROPE SMALL MOLECULE API MARKET, BY TYPE 47
FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 48
FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 49
FIGURE 14 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58
FIGURE 15 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 59
FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 60
FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 61
FIGURE 18 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 71
FIGURE 19 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE 73
FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION 74
FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 75
FIGURE 22 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 76